Amneal Pharmaceuticals Inc Class A (AMRX)
R&D Expense Growth
7.09%
Quarterly · Period ending:
AMRX R&D Expense Growth
Latest reported7.09%period ending
Latest reported7.09%period ending
AMRX Quarterly R&D Growth (QoQ) (0.00% → 7.09%)
Latest values, visible window
High-resolution chart · PNG
AMRX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 7.0891% | |
| 10.2358% | |
| -45.0388% | |
| 26.7522% | |
| 19.5517% | |
| -25.5003% | |
| -8.151% | |
| 64.6997% | |
| -5.6033% | |
| -15.6043% | |
| 10.182% | |
| 9.4306% | |
| -4.252% | |
| -6.7831% | |
| -16.22% | |
| 0.1493% | |
| -3.7209% | |
| 1.0299% | |
| 4.87% | |
| -6.7768% | |
| 4.762% | |
| -9.4418% | |
| 22.5237% | |
| -5.0263% | |
| 30.4736% | |
| -28.9976% | |
| 30.2474% | |
| -19.4272% | |
| -12.9205% | |
| -4.1464% | |
| 27.7089% | |
| -12.8388% | |
| 11.4728% | |
| 5.5358% | |
| -3.7279% | |
| -7.8565% | |
| 32.1951% | |
| -9.4087% | |
| 0% |